Fri. Jul 19th, 2019


The Tactical Swing Trader

Palatin Technologies (PTN) developed a drug which is suppose to help combat hypoactive sexual desire disorder (aka HDD). Here is my take on why this stock did not explode after FDA approval.

Leave a Reply

Your email address will not be published. Required fields are marked *